JPS55113794A - Novel cephalosporin derivative*its manufacture and use as antibacterial - Google Patents
Novel cephalosporin derivative*its manufacture and use as antibacterialInfo
- Publication number
- JPS55113794A JPS55113794A JP1844280A JP1844280A JPS55113794A JP S55113794 A JPS55113794 A JP S55113794A JP 1844280 A JP1844280 A JP 1844280A JP 1844280 A JP1844280 A JP 1844280A JP S55113794 A JPS55113794 A JP S55113794A
- Authority
- JP
- Japan
- Prior art keywords
- antibacterial
- manufacture
- cephalosporin derivative
- novel cephalosporin
- novel
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D231/18—One oxygen or sulfur atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D231/38—Nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D231/38—Nitrogen atoms
- C07D231/40—Acylated on said nitrogen atom
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Communicable Diseases (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Cephalosporin Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH154579A CH641810A5 (en) | 1979-02-16 | 1979-02-16 | Acetamidocephalosporanic acid derivatives, process for their preparation and pharmaceutical forms which contain them |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JPS55113794A true JPS55113794A (en) | 1980-09-02 |
Family
ID=4212918
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP1844280A Pending JPS55113794A (en) | 1979-02-16 | 1980-02-15 | Novel cephalosporin derivative*its manufacture and use as antibacterial |
Country Status (4)
| Country | Link |
|---|---|
| JP (1) | JPS55113794A (en) |
| BE (1) | BE881641A (en) |
| CH (1) | CH641810A5 (en) |
| ZA (1) | ZA80885B (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH648038A5 (en) * | 1981-01-19 | 1985-02-28 | Sandoz Ag | 7-((carboxymethoxyimino)-1h-pyrazol-3-yl-acetyl)amino-3-desacetoxy-3-(1-methyl-1h-tetrazol-5-yl-thio)cephalosporansaeure and salts, method for production and use. |
-
1979
- 1979-02-16 CH CH154579A patent/CH641810A5/en not_active IP Right Cessation
-
1980
- 1980-02-11 BE BE1/9716A patent/BE881641A/en not_active IP Right Cessation
- 1980-02-15 JP JP1844280A patent/JPS55113794A/en active Pending
- 1980-02-15 ZA ZA00800885A patent/ZA80885B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CH641810A5 (en) | 1984-03-15 |
| BE881641A (en) | 1980-08-11 |
| ZA80885B (en) | 1981-09-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB2063871B (en) | Cephalosporin antibiotic | |
| PH15929A (en) | 3-thiovinyl cephalosporin | |
| JPS55113790A (en) | Novel penicillanic ester derivative and its manufacture and use | |
| JPS5683488A (en) | Antibacterial and its manufacture | |
| GB2064513B (en) | Cephalosporin antibiotic | |
| JPS55154978A (en) | Novel cephalosporins and their manufacture | |
| JPS5517391A (en) | Alphaaazolyllketo derivative*its manufacture and antibacterial containing it | |
| JPS55154981A (en) | Novel 33vinyllcephalosporin derivative and its manufacture | |
| MY8500128A (en) | New cephalosporin derivatives, their production and use as antimicrobial agents | |
| JPS55129267A (en) | 33substituted pyridine derivative* its manufacture and use as antibacterial | |
| GB2060610B (en) | Desaacetyl cephalosporin c production | |
| JPS5687569A (en) | Oxybutyllimidazole derivative* its manufacture and its use as bactericide | |
| JPS55111477A (en) | 11vinyltriazole derivative*its manufacture and its use as growth regulator and antibacterial | |
| JPS55108871A (en) | Novel norrtropane derivative*its manufacture and use | |
| IL59680A0 (en) | Cephalosporin antibiotics | |
| NZ192943A (en) | Cephalosporin antibiotics | |
| JPS55100392A (en) | Novel cephalosporin derivative* its manufacture and use | |
| JPS55129251A (en) | Substituted nnaryllacetoanilide*its manufacture and use as antibacterial | |
| GB2046261B (en) | Cephalosporin antibiotics | |
| JPS55167286A (en) | Novel 22phenyll44pyrone derivative* its manufacture and its application as bactericide | |
| GB2049688B (en) | Cephalosporin derivatives processes for the preparation thereof and antibacterial compositions containing them | |
| JPS55113794A (en) | Novel cephalosporin derivative*its manufacture and use as antibacterial | |
| JPS55129205A (en) | Antibacterial composition | |
| JPS55167290A (en) | Cephalosporin antibiotic | |
| JPS55115888A (en) | Cephalosporin antibiotic |